{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:08:44Z","timestamp":1788570524179,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.imbio.2021.152058","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T04:25:38Z","timestamp":1611375938000},"page":"152058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Glycosylation is required for the neutralizing activity of human IgG1 antibodies against human rabies induced by pre-exposure prophylaxis"],"prefix":"10.1016","volume":"226","author":[{"given":"Gabriela","family":"Koike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iana Suly Santos","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Raniero","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandriana Ramos","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.imbio.2021.152058_b0005","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s00705-016-2880-1","article-title":"Taxonomy of the order Mononegavirales: update 2016","volume":"161","author":"Afonso","year":"2016","journal-title":"Arch. Virol."},{"issue":"4","key":"10.1016\/j.imbio.2021.152058_b0010","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4161\/mabs.20450","article-title":"Increased serum clearance of oligomannose species present on a human IgG1 molecule","volume":"4","author":"Alessandri","year":"2012","journal-title":"mAbs"},{"key":"10.1016\/j.imbio.2021.152058_b0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.smim.2018.05.003","article-title":"Antibody glycosylation in inflammation, disease and vaccination","volume":"39","author":"Alter","year":"2018","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2021.152058_b0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","article-title":"The impact of glycosylation on the biological function and structure of human immunoglobulins","volume":"25","author":"Arnold","year":"2007","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.imbio.2021.152058_b0025","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/S1678-91992006000300008","article-title":"Antibody and cytokine serum levels in patients subjected to anti-rabies prophylaxis with serum-vaccination","volume":"12","author":"Ayres","year":"2006","journal-title":"J. Venomous Anim. Toxins Incl. Trop. Dis."},{"issue":"6","key":"10.1016\/j.imbio.2021.152058_b0030","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1023\/B:JOCI.0000010429.36461.6b","article-title":"Vaccination with rabies to study the humoral and cellular immune response to a T-cell dependent neoantigen in man","volume":"23","author":"Brinkman","year":"2003","journal-title":"J. Clin. Immunol."},{"issue":"1-2","key":"10.1016\/j.imbio.2021.152058_b0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-1759(99)00223-9","article-title":"The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure","volume":"235","author":"Champion","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.imbio.2021.152058_b0040","series-title":"Resposta imune humoral na imuniza\u00e7\u00e3o anti-r\u00e1bica humana: compara\u00e7\u00e3o de t\u00edtulos de anticorpos neutralizantes de isotipos de imunoglobulinas e de avidez de IgG na vacina\u00e7\u00e3o intramuscular e intrad\u00e9rmica [masters dissertation]","author":"Chaves","year":"1997"},{"issue":"4","key":"10.1016\/j.imbio.2021.152058_b0045","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1167\/iovs.11-9291","article-title":"Glucosamine modulates TNF-\u03b1-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells","volume":"53","author":"Chen","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.imbio.2021.152058_b0050","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1590\/S0034-89102010005000005","article-title":"Equivalence between pre-exposure schemes for human rabies and evaluation of the need for serological monitoring","volume":"44","author":"Cunha","year":"2010","journal-title":"Rev. Saude Publ."},{"key":"10.1016\/j.imbio.2021.152058_b0055","doi-asserted-by":"crossref","first-page":"101867","DOI":"10.1016\/j.tmaid.2020.101867","article-title":"Factors influencing the immune response after a single-dose 3-visit pre-exposure rabies intradermal vaccination schedule: A retrospective multivariate analysis","volume":"37","author":"Damanet","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"issue":"5","key":"10.1016\/j.imbio.2021.152058_b0065","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/infdis\/156.5.815","article-title":"Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody","volume":"156","author":"Dietzschold","year":"1987","journal-title":"J. Infect. Dis."},{"issue":"3-4","key":"10.1016\/j.imbio.2021.152058_b0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(79)90133-9","article-title":"pH gradient elution of human IgG1, IgG2 and IgG4 from protein A-Sepharose","volume":"31","author":"Duhamel","year":"1979","journal-title":"J. Immunol. Methods"},{"issue":"Pt 2","key":"10.1016\/j.imbio.2021.152058_b0075","first-page":"279","article-title":"Glycobiology: 'the function of sugar in the IgG molecule'","volume":"187","author":"Dwek","year":"1995","journal-title":"J. Anat."},{"issue":"9951","key":"10.1016\/j.imbio.2021.152058_b0085","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(13)62707-5","article-title":"Current status of rabies and prospects for elimination","volume":"384","author":"Fooks","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.imbio.2021.152058_b0090","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.91","article-title":"Rabies","volume":"3","author":"Fooks","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.imbio.2021.152058_b0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.chroma.2015.03.080","article-title":"Transient conformational modification of immunoglobulin G during purification by protein A affinity chromatography","volume":"1395","author":"Gagnon","year":"2015","journal-title":"J. Chromatogr. A"},{"issue":"7","key":"10.1016\/j.imbio.2021.152058_b0100","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/glycob\/cwr027","article-title":"High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans","volume":"21","author":"Goetze","year":"2011","journal-title":"Glycobiology"},{"key":"10.1016\/j.imbio.2021.152058_b0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0065-2318(08)60220-6","article-title":"The lectins: carbohydrate-binding proteins of plants and animals","volume":"35","author":"Goldstein","year":"1978","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"issue":"18","key":"10.1016\/j.imbio.2021.152058_b0110","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1021\/ol051383e","article-title":"De Novo asymmetric synthesis of daumone via a palladium-catalyzed glycosylation","volume":"7","author":"Guo","year":"2005","journal-title":"Org. Lett."},{"key":"10.1016\/j.imbio.2021.152058_b0115","doi-asserted-by":"crossref","unstructured":"Hamilton R. G. (1987). Human IgG subclass measurements in the clinical laboratory. Clin. Chem., 33(10), 1707\u20131725.","DOI":"10.1093\/clinchem\/33.10.1707"},{"issue":"4","key":"10.1016\/j.imbio.2021.152058_b0120","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bbagen.2005.11.021","article-title":"Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis","volume":"1760","author":"Holland","year":"2006","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Gen. Subj."},{"issue":"9","key":"10.1016\/j.imbio.2021.152058_b0125","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1517\/14712598.7.9.1401","article-title":"Antibody therapeutics:: isotype and glycoform selection","volume":"7","author":"Jefferis","year":"2007","journal-title":"Expert Opin. Biol. Ther."},{"issue":"23","key":"10.1016\/j.imbio.2021.152058_b0130","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1016\/j.vaccine.2010.03.039","article-title":"The immune response to rabies virus infection and vaccination","volume":"28","author":"Johnson","year":"2010","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.imbio.2021.152058_b0135","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s00705-017-3484-0","article-title":"Immunological aspects of rabies: a literature review","volume":"162","author":"Katz","year":"2017","journal-title":"Arch. Virol."},{"key":"10.1016\/j.imbio.2021.152058_b0140","doi-asserted-by":"crossref","unstructured":"Kiyoshi, M., Tsumoto, K., Ishii-Watabe, A., Caaveiro, J. (2017). Glycosylation of IgG-Fc: a molecular perspective. Int. Immunol., 29(7), 311\u2013317. https:\/\/doi.org\/10.1093\/intimm\/dxx038.","DOI":"10.1093\/intimm\/dxx038"},{"issue":"5259","key":"10.1016\/j.imbio.2021.152058_b0145","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2021.152058_b0150","doi-asserted-by":"crossref","unstructured":"Langedijk A.C., De Pijper C.A., Spijker R., Holman R., Grobusch M.P., Stijnis C. (2018). Rabies antibody response after booster immunization: a systematic review and meta-analysis. Clin. Infect. Dis. 67(12):1932-1947. doi:10.1093\/cid\/ciy420.","DOI":"10.1093\/cid\/ciy420"},{"issue":"6","key":"10.1016\/j.imbio.2021.152058_b0155","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.3892\/mmr.2017.6523","article-title":"Purification of a polyclonal antibody against CD147 for ELISA using antigen-immunoaffinity chromatography","volume":"15","author":"Liu","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.imbio.2021.152058_b0160","doi-asserted-by":"crossref","unstructured":"Mahan, A. E., Jennewein, M. F., Suscovich, T., Dionne, K., Tedesco, J., Chung, A. W., Streeck, H., Pau, M., Schuitemaker, H., Francis, D., Fast, P., Laufer, D., Walker, B. D., Baden, L., Barouch, D. H.,Alter, G. (2016). Antigen-specific antibody glycosylation is regulated via vaccination. PLoS Pathog., 12(3), e1005456. https:\/\/doi.org\/10.1371\/journal.ppat.1005456.","DOI":"10.1371\/journal.ppat.1005456"},{"issue":"5","key":"10.1016\/j.imbio.2021.152058_b0165","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF01954221","article-title":"Sialic acid binding lectins","volume":"46","author":"Mandal","year":"1990","journal-title":"Experientia"},{"key":"10.1016\/j.imbio.2021.152058_b0170","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3389\/fimmu.2017.01175","article-title":"Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein","volume":"8","author":"Maeda","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2021.152058_b0175","doi-asserted-by":"crossref","unstructured":"O\u2019Kennedy R, Murphy C.,Devine T (2016). Technology advancements in antibody purification, Antib. Technol. J., 6, 17\u201332.","DOI":"10.2147\/ANTI.S64762"},{"issue":"2","key":"10.1016\/j.imbio.2021.152058_b0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0092-1157(86)90027-2","article-title":"The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virus","volume":"14","author":"Perrin","year":"1986","journal-title":"J. Biol. Standard."},{"issue":"1","key":"10.1016\/j.imbio.2021.152058_b0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1590\/S0036-46651999000100008","article-title":"An ELISA suitable for the detection of rabies virus antibodies in serum samples from human vaccinated with either cell-culture vaccine or suckling-mouse-brain vaccine","volume":"41","author":"Piza","year":"1999","journal-title":"Rev. Inst. Med. Trop. S. Paulo"},{"issue":"7","key":"10.1016\/j.imbio.2021.152058_b0190","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin. Vacc. Immunol."},{"issue":"1-2","key":"10.1016\/j.imbio.2021.152058_b0195","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.imlet.2011.01.017","article-title":"Progesterone induces a switch in oligosaccharyltransferase isoform expression: Consequences on IgG N-glycosylation","volume":"137","author":"Prados","year":"2011","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.imbio.2021.152058_b0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(86)90268-1","article-title":"Antibody avidity determination by ELISA using thiocyanate elution","volume":"86","author":"Pullen","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.imbio.2021.152058_b0205","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.virusres.2018.02.012","article-title":"Revisiting rabies virus neutralizing antibodies through infecting BALB\/c mice with live rabies virus","volume":"248","author":"Qin","year":"2018","journal-title":"Virus Res."},{"issue":"2","key":"10.1016\/j.imbio.2021.152058_b0210","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1006\/viro.1995.1356","article-title":"Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing","volume":"210","author":"Raux","year":"1995","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.imbio.2021.152058_b0220","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/annrheumdis-2014-206598","article-title":"Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis","volume":"75","author":"Rombouts","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imbio.2021.152058_b0225","unstructured":"Rupprecht CE, Fooks AR, Abela-Ridder B, editors. Laboratory techniques in rabies, fifth edition. Volume 2. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"1","key":"10.1016\/j.imbio.2021.152058_b0230","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1038\/s41598-020-59651-7","article-title":"IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia","volume":"10","author":"Schmidt","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imbio.2021.152058_b0235","doi-asserted-by":"crossref","unstructured":"Selman, M. H., de Jong, S. E., Soonawala, D., Kroon, F. P., Adegnika, A. A., Deelder, A. M., Hokke, C. H., Yazdanbakhsh, M., Wuhrer, M. (2012). Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination. Mol. Cell. Proteom., 11(4), M111.014563. https:\/\/doi.org\/10.1074\/mcp.M111.014563.","DOI":"10.1074\/mcp.M111.014563"},{"issue":"12","key":"10.1016\/j.imbio.2021.152058_b0240","doi-asserted-by":"crossref","first-page":"8308","DOI":"10.4049\/jimmunol.181.12.8308","article-title":"Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies","volume":"181","author":"Silva","year":"2008","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2021.152058_b0245","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/01652176.2017.1343516","article-title":"Rabies - epidemiology, pathogenesis, public health concerns and advances in diagnosis and control: a comprehensive review","volume":"37","author":"Singh","year":"2017","journal-title":"Vet. Q."},{"issue":"5","key":"10.1016\/j.imbio.2021.152058_b0250","first-page":"535","article-title":"A rapid reproducible test for determining rabies neutralizing antibody","volume":"48","author":"Smith","year":"1973","journal-title":"Bull. World Health Organ."},{"issue":"6","key":"10.1016\/j.imbio.2021.152058_b0255","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1177\/1087057115577597","article-title":"A quantitative microtiter assay for sialylated glycoform analyses using lectin complexes","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Biomol. Screen."},{"issue":"11","key":"10.1016\/j.imbio.2021.152058_b0260","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.trstmh.2009.03.007","article-title":"Immunogenicity and booster efficacy of pre-exposure rabies vaccination","volume":"103","author":"Strady","year":"2009","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.imbio.2021.152058_b0265","first-page":"1435","article-title":"The emerging importance of IgG Fab glycosylation in immunity","volume":"196","author":"van de Bovenkamp","year":"2016","journal-title":"J.I."},{"key":"10.1016\/j.imbio.2021.152058_b0270","series-title":"Methods on Glycoconjugates","author":"Verbet","year":"1995"},{"issue":"2","key":"10.1016\/j.imbio.2021.152058_b0275","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/iid3.22","article-title":"A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines","volume":"2","author":"Vestrheim","year":"2014","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.imbio.2021.152058_b0285","doi-asserted-by":"crossref","unstructured":"Wang, J., Balog, C. I., Stavenhagen, K., Koeleman, C. A., Scherer, H. U., Selman, M. H., Deelder, A. M., Huizinga, T. W., Toes, R. E., Wuhrer, M. (2011). Fc-glycosylation of IgG1 is modulated by B-cell stimuli. Mol. Cell. Proteom., 10(5), M110.004655. https:\/\/doi.org\/10.1074\/mcp.M110.004655.","DOI":"10.1074\/mcp.M110.004655"},{"key":"10.1016\/j.imbio.2021.152058_b0290","doi-asserted-by":"crossref","unstructured":"Wang, T. T., Ravetch, J. V. (2019). Functional diversification of IgGs through Fc glycosylation. J. Clin. Invest., 129(9), 3492\u20133498. https:\/\/doi.org\/10.1172\/JCI130029.","DOI":"10.1172\/JCI130029"},{"key":"10.1016\/j.imbio.2021.152058_b0295","unstructured":"Warburg, O, Christian, W. (1941). Spectrophotometric method for the determination of protein and nucleic acids, Biochem. Z, 310, 384\u2013421."},{"issue":"Pt 6","key":"10.1016\/j.imbio.2021.152058_b0300","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1099\/jmm.0.006064-0","article-title":"An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodies","volume":"58","author":"Welch","year":"2009","journal-title":"J. Med. Microbiol."},{"issue":"37","key":"10.1016\/j.imbio.2021.152058_b0305","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.vaccine.2018.06.061","article-title":"Rabies Vaccines: WHO Position Paper, April 2018 \u2013 Recommendations","volume":"36","author":"World Health Organization","year":"2018","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.imbio.2021.152058_b0310","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/j.1460-2075.1991.tb07819.x","article-title":"Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure","volume":"10","author":"Wright","year":"1991","journal-title":"EMBO J."},{"issue":"2\u20133","key":"10.1016\/j.imbio.2021.152058_b0315","first-page":"259","article-title":"Antibody variable region glycosylation: biochemical and clinical effects","volume":"15","author":"Wright","year":"1993","journal-title":"Springer Semin. Immunopathol."},{"issue":"4","key":"10.1016\/j.imbio.2021.152058_b0320","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1021\/pr401061c","article-title":"Analysis of glycan variation on glycoproteins from serum by the reverse lectin-based ELISA assay","volume":"13","author":"Wu","year":"2014","journal-title":"J. Proteome Res."},{"issue":"41","key":"10.1016\/j.imbio.2021.152058_b0325","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1016\/j.vaccine.2019.08.043","article-title":"Rabies virus glycoprotein serology ELISA for measurement of neutralizing antibodies in sera of vaccinated human subjects","volume":"37","author":"Zhao","year":"2019","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.imbio.2021.152058_b0330","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/19420862.2016.1149662","article-title":"The use of lectin microarray for assessing glycosylation of therapeutic proteins","volume":"8","author":"Zhang","year":"2016","journal-title":"mAbs"},{"issue":"2","key":"10.1016\/j.imbio.2021.152058_b0335","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/19420862.2015.1117719","article-title":"Glycan analysis of therapeutic glycoproteins","volume":"8","author":"Zhang","year":"2016","journal-title":"mAbs"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298521000061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298521000061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:48:25Z","timestamp":1759250905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298521000061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0171298521000061"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2021.152058","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycosylation is required for the neutralizing activity of human IgG1 antibodies against human rabies induced by pre-exposure prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2021.152058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152058"}}